# Tracon Pharmaceuticals, Inc.

Tracon Pharmaceuticals, Inc. is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** Tracon Pharmaceuticals, Inc.
- **Former names in filing history:** Tracon Pharmaceuticals Inc (2007-03-22 to 2014-09-15)
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** San Diego, CA, United States
- **Fiscal year end:** December 31
- **SEC CIK:** 0001394319

## About

Tracon Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001394319, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2024-03-05, it reported annual revenue of USD 12,045,000; net income of USD -3,588,000; total assets of USD 10,105,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $12.0M (USD 12,045,000)
- **Net income:** -$3.6M (USD -3,588,000)
- **Total assets:** $10.1M (USD 10,105,000)
- **Cash and equivalents:** $8.6M (USD 8,564,000)
- **Operating cash flow:** $3.7M (USD 3,676,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$29.1M (USD -29,135,000)
- **Total assets:** $19.5M (USD 19,469,000)
- **Cash and equivalents:** $17.4M (USD 17,433,000)
- **Operating cash flow:** -$26.2M (USD -26,239,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $346,000 (USD 346,000)
- **Net income:** -$28.7M (USD -28,667,000)
- **Total assets:** $26.6M (USD 26,557,000)
- **Cash and equivalents:** $24.1M (USD 24,072,000)
- **Operating cash flow:** -$22.6M (USD -22,571,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$16.8M (USD -16,775,000)
- **Total assets:** $37.4M (USD 37,438,000)
- **Cash and equivalents:** $32.1M (USD 32,131,000)
- **Operating cash flow:** -$17.0M (USD -17,042,000)

## Recent SEC filings

- Form 8-K — filed 2024-10-11 — period 2024-10-11 — 8-K
- Form DEF 14A — filed 2024-08-30 — period 2024-10-11 — DEF 14A
- Form 10-Q — filed 2024-08-13 — period 2024-06-30 — 10-Q
- Form 8-K — filed 2024-07-30 — period 2024-07-26 — 8-K
- Form 8-K — filed 2024-07-16 — period 2024-07-12 — 8-K
- Form 8-K — filed 2024-07-01 — period 2024-07-01 — 8-K
- Form 8-K — filed 2024-06-21 — period 2024-06-19 — 8-K
- Form 8-K — filed 2024-06-12 — period 2024-06-11 — 8-K
- Form 10-Q — filed 2024-05-14 — period 2024-03-31 — 10-Q
- Form 8-K — filed 2024-05-14 — period 2024-05-14 — 8-K
- Form 8-K — filed 2024-05-13 — period 2024-05-08 — 8-K
- Form S-1 — filed 2024-04-12 — S-1

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/tracon-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology